Joanne Van Zuidam
Editor

Joanne Van Zuidam is the editor of Drug Discovery & Development. An experienced health editor, she previously served as editor of Optometric Office magazine, a publication highlighting new products and technology for eye care professionals. As a freelance writer, she has written extensively on a broad range of health and wellness topics for numerous national magazines and websites. 

Oracle Health Sciences recently launched Oracle Clinical One, a cloud-based eClinical platform created to help bring drugs to market faster. We spoke with...
7.26.2017
11:48am
Patients in nursing homes that received a high-dose flu vaccine were significantly less likely than residents in homes receiving standard-dose vaccines to go...
7.24.2017
11:38am
The Alzheimer’s Association announced its plans for a $20 million lifestyle intervention trial to prevent cognitive decline in the U.S. at the 2017 Alzheimer...
7.21.2017
11:26am
Healthy eating may preserve cognitive function and reduce the risk of dementia. That’s according to findings from four studies presented at the 2017 Alzheimer’...
7.21.2017
11:05am
Janssen Biotech, Inc., a division of Johnson & Johnson, has announced U.S. FDA approval of guselkumab (Tremfya) for the treatment of moderate to severe...
7.17.2017
11:40am
Advertisement
Data from HAVEN 1 was released at the International Society of Thrombosis and Hemostasis (ISTH) and published in the New England Journal of Medicine. Interim...
7.14.2017
10:39am
The best thing about waking up? It may be the health benefits in your cup. Two large (or should we say, Venti?) studies found coffee consumption associated...
7.12.2017
12:09pm
Researchers at Case Western Reserve University found high doses of vitamin D may reduce swelling, redness, and inflammation after sunburn.
7.7.2017
11:04am
Drug Discovery & Development spoke with Glenmark’s president and chief medical officer, Fred Grossman, DO, FAPA, who presented at the 2017 BIO...
7.6.2017
10:53am
The FDA committed to eliminate the backlog within 90 days and responding to all new requests for designation within 90 days of receipt.
6.30.2017
11:46am
Today is National HIV Testing Day. The campaign from the Centers for Disease Control and Prevention (CDC) raises awareness of testing for early diagnosis of...
6.27.2017
11:49am
Haegarda is a self-administered, plasma-derived concentrate of C1 esterase inhibitor (C1-INH) injected twice weekly subcutaneously.
6.26.2017
11:56am
The new formulation of rituximab can be administered in five to seven minutes via injection versus 90 minutes or longer with intravenous infusion.
6.23.2017
12:05pm
Advertisement
Lion Biotechnologies, Inc.’s LN-144 achieved a 29 percent objective response rate in a study of patients with advanced metastatic melanoma.
6.23.2017
10:28am
Goals of the Institute for Protein Innovation include training the next generation of protein scientists and entrepreneurs, building a large catalog of...
6.22.2017
11:34am
The study, published in Annals of Neurology, was based on a hypothesis that targeting limbic neural pathways would modulate the affective sphere of pain and...
6.21.2017
11:52am
A three-in-one blood test developed by British researchers may help determine which men would benefit most from PARP inhibitors—by testing circulating cancer...
6.20.2017
12:05pm
The U.S. Food and Drug Administration (FDA) approved Adamis Pharmaceutical’s EPINEPHRINE INJECTION, USP, 1:1000 (0.3 mg Pre-filled single dose syringe) for the...
6.16.2017
11:42am
The new trial will enroll approximately 5,000 people with chronic kidney disease—both with and without type 2 diabetes.
6.16.2017
10:23am
Canagliflozin (Invokana) significantly reduced the combined risk of cardiovascular death, myocardial infarction, and nonfatal stroke, versus placebo in...
6.13.2017
12:23pm
Flexion Therapeutics, Inc. presented data from a Phase II study which found its lead investigational drug candidate, FX006 (Zilretta) was associated with...
6.12.2017
11:44am
Advertisement
Investigators from Brigham and Women's Hospital found that patients are twice as likely to experience diabetic ketoacidosis if taking sodium-glucose...
6.9.2017
11:28am
Acorda Therapeutics, Inc. presented data from its Phase III SPAN-PD clinical trial of CVT-301, which showed a statistically significant improvement in motor...
6.7.2017
12:13pm
EGFR tyrosine kinase inhibitors (TKI) are the standard treatment for the disease. The phase III study is the first phase III head-to-head comparison of two...
6.6.2017
12:09pm
Findings presented at the American Society of Clinical Oncology (ASCO) meeting Saturday, June 4 show that PARP inhibitors may offer a new type of treatment for...
6.5.2017
3:33pm
In 2016 alone, 2.3 million Ohio patients – roughly 20% of the state’s population – were prescribed an opioid drug.
6.2.2017
11:58am
Approval of Zerviate was granted to Nicox three months ahead of its PDUFA date of September 8, 2017.
6.1.2017
11:25am
Apotex Inc., Teva Pharmaceuticals USA Inc., Aurobindo Pharma Limited and Glenmark Pharmaceuticals Limited were granted approval to market the generic in...
5.31.2017
11:05am
A new study found patients with severe asthma treated with benralizumab, a potential new medicine, were more than four times likely to reduce their usage of...
5.26.2017
11:16am
The Member States of World Health Organization (WHO) elected Tedros Adhanom Ghebreyesus, Ph.D., of Ethiopia as the new Director-General of WHO.
5.24.2017
11:27am
This is the sixth FDA approval for Actemra since it was launched in 2010—and the first drug approved to specifically treat patients with Giant Cell Arteritis.
5.23.2017
11:58am
Among patients with persistent hypercapnia (excess carbon dioxide in their blood) following a COPD exacerbation, the addition of a home ventilator device to...
5.22.2017
12:08pm
The disease is endemic in approximately 60 countries and causes epidemics as well. It is estimated that cholera results in 2.9 million cases of disease and 95,...
5.19.2017
11:59am
Based on two clinical trials, the FDA has concluded that the type 2 diabetes drug canagliflozin, manufactured by Johnson & Johnson, causes an increased...
5.18.2017
12:51pm
Researchers in an international clinical trial tested whether the blood clot stabilizer could become an essential tool for fighting excessive bleeding soon...
5.16.2017
12:02pm
Researchers from the Intermountain Medical Center Transplant Program found that liver transplant patients taking everolimus (Afinitor) gained less weight – and...
5.15.2017
12:34pm
FDA actions included three drug withdrawals, 61 boxed warnings and 59 safety communications, according to a Yale-led study.
5.10.2017
8:55am
Aspergillus niger-derived prolyl endoprotease (AN-PEP), was found to break down small amounts of gluten within the digestive system.
5.8.2017
11:53am
Quest Diagnostics has agreed to pay $6 million to resolve a lawsuit brought by the United States government that alleged that Berkeley Heartlab—a Quest...
5.5.2017
10:32am